Yüklüyor......
Effectiveness of sacubitril–valsartan in cancer patients with heart failure
AIMS: Current guidelines recommend sacubitril/valsartan for patients with heart failure and reduced left ventricular ejection fraction (LVEF), but there is lack of evidence of its efficacy and safety in cancer therapy‐related cardiac dysfunction (CTRCD). Our aim was to analyse the potential benefit...
Kaydedildi:
| Yayımlandı: | ESC Heart Fail |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160493/ https://ncbi.nlm.nih.gov/pubmed/32022485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12627 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|